Department of Health and Human Services with stylized eagle made up of silhouetted human faces C D C
Department of Health and Human Services
Centers for Disease Control and Prevention

National Institute for Occupational Safety and Health (NIOSH)
Search NIOSH NIOSH Home NIOSH Topics Site Index Databases and Information Resources NIOSH Products Contact Us

NIOSH Program Area:

Radiation Dose Reconstruction

 

Advisory Board

 

The Advisory Board on Radiation and Worker Health was appointed by the President to advise the Department of Health and Human Services on its activities under The Act. The Act specified that the Board will include a balance of perspectives from scientists, physicians, and workers.

Advisory Board on Radiation and Worker Health Members

Row 1 (seated): R. William Field, Paul Ziemer, David B. Richardson, James Melius, Henry A. Anderson, Richard A. Lemen, James Lockey, Josie Beach

Row 2 (standing): Ted Katz (NIOSH), Wanda Munn, Mark Griffin, John Poston, Phillip Schofield, Robert Presley, Bradley Clawson, Michael Gibson, Genevieve Roessler

In Memoriam: Robert W. Presley


Robert W. Presley Robert "Bob" Winton Presley, a member of the Advisory Board on Radiation and Worker Health since its inception in 2001, passed away on September 21, 2011, at his home after a brief illness with cancer. He was a prized member of the Advisory Board. The Advisory Board benefitted from Bob's broad expertise in nuclear weapons operations, his compassion for his fellow nuclear weapons workers, and his faultless integrity. Bob worked for the U.S. nuclear weapons complex for more than four decades and epitomized the commitment and pride of this workforce in contributing to the protection of Americans and peoples around the World. He was also the kindest of men and dedicated to his family and community. His fellow Advisory Board Members and members of NIOSH and SC&A staff will miss him and commend his memory to the public we serve.
Top of Page

Advisory Board Charter

Authority

The Advisory Board on Radiation and Worker Health was established under Executive Order 13179, dated December 7, 2000, and Public Law 106-398, Section 3624(a)(1). The Board is governed by the provisions of Public Law 92-463, as amended (5 U.S.C. App. 2), which sets forth standards for the formation and use of advisory committees.

Objective and Scope of Activities

The President is authorized by Public Law 106-398 to carry out the Energy Employees Occupational Illness Compensation Program Act of 2000. Since World War II, many men and women have served in building the Nation's nuclear defense and, in the course of this work, have been exposed to beryllium, ionizing radiation, and other hazards unique to nuclear weapons production and testing. The purpose of the compensation program is to provide for timely, uniform, and adequate compensation of covered employees and, where applicable, survivors of such employees, suffering from illnesses incurred by such employees in the performance of duty for the Department of Energy (DOE) and certain of its contractors and subcontractors.

The Secretaries of Energy, Health and Human Services, and Labor share responsibilities for administering the compensation program. Section 3624 of Public Law 106-398 authorizes the President to establish and appoint an Advisory Board on Radiation and Worker Health, and by Executive Order 13179, the President has designated responsibility for the Board to the Secretary, Department of Health and Human Services (HHS).

Description of Duties

Section 4(b) of Executive Order 13179 establishes that the Board shall provide advice to the Secretary, HHS on (1) the development of guidelines to assess the likelihood that an individual with cancer sustained the cancer in the performance of duty at a Department of Energy facility or an Atomic Weapons Employer (AWE) facility, and methods for arriving at and providing reasonable estimates of the radiation doses received by individuals applying for assistance under this program for whom there are inadequate records of radiation exposure; (2) the scientific validity and quality of dose reconstruction efforts performed for this Program; and (3) upon request by the Secretary, whether there is a class of employees at any DOE or AWE facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of the class.

Agency or Official to Whom the Board Reports

The Board shall provide advice to the Secretary, HHS on the development of guidelines under section 4(b) of Executive Order 13179.

Support

The Department of Health and Human Services shall provide administrative services, funds, facilities, staff, and other necessary support services, and perform the administrative functions of the President under the Federal Advisory Committee Act, as amended (5 U.S.C. App.), with respect to the Board.

Estimated Annual Operating Costs and Staff Years

Estimated annual cost for operating the Board, including compensation and travel expenses for members, but excluding staff support, is $867,785. Estimate of annual person-years of staff support required is 4.15, at an estimated annual cost of $767,785.

Designated Federal Officer

The Centers for Disease Control and Prevention (CDC) will select a full-time or permanent part-time Federal employee to serve as the Designated Federal Officer (DFO) to attend each Board meeting and ensure that all procedures are within applicable statutory, regulatory, and HHS General Administration Manual directives. The DFO will approve and prepare all meeting agendas, call all of the Board and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the official to whom the Board reports. The DFO or his/her designee shall be present at all meetings of the full Board and subcommittees.

Estimated Number and Frequency of Meetings

The frequency of meetings shall be determined by the National Institute for Occupational Safety and Health, CDC, based on agency needs at the call of the DFO, in consultation with the Chair.

Meetings shall be open to the public except as determined otherwise by the Secretary, HHS, or other official to whom the authority has been delegated; in accordance with the Government in the Sunshine Act (5 U.S.C. 552b(c)) and Section 10(d) of the Federal Advisory Committee Act; notice of all meetings shall be given to the public.

Duration

Continuing

Termination Date

Unless renewed by appropriate action prior to its expiration, the Advisory Board on Radiation and Worker Health will terminate two years from the date this charter is filed.

Membership and Designation

The Board shall consist of not more than 20 public members to be appointed by the President. In accordance with EEOICPA, 42 U.S.C. § 7384o(a)(2)and (3), the President shall make appointments to the Board in consultation with organizations with expertise on worker health issues in order to ensure that the membership of the Board reflects a balance of scientific, medical, and worker perspectives. The President shall designate a Chair for the Board from among its members.

Subcommittees

Subcommittees composed of members of the parent committee may be established with the approval of the Secretary, HHS or his/her designee. The subcommittees must report back to the parent committee and do not provide advice or work products directly to the agency. The Department Committee Management Officer will be notified upon establishment of each subcommittee and will be provided information on its name, membership, functions, and estimated frequency of meetings.

Recordkeeping

The records of the Board, established subcommittees of the Board, shall be managed in accordance with General Records Schedule 26, Item 2 or other approved agency records disposition schedule. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552.

Filing Date

August 3, 2011

Top of Page

Advisory Board Members

The Board has been appointed by the President. Below is the current roster of members:

  • Chair

    • James Malcolm Melius, M.D., Dr. P.H.
      Director
      New York State Laborers' Health and Safety Trust Fund
      Albany, New York

      Dr. Melius has served as Director for the New York State Laborers' Health and Safety Trust Fund in Albany, New York since 1996. Other current appointments and activities of Dr. Melius include: Director, New York State Laborers' Employers Cooperation and Education Trust Fund since 1997; and Research Director, Laborers' Health and Safety Fund of North America since 1995.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 10 KB (1 page)

  • Designated Federal Official

    • Ted Katz
      Program Analyst (Regulatory Impact)
      National Institute for Occupational Safety and Health (NIOSH)
      Atlanta, GA

  • Membership

    • Henry A. Anderson, M.D.
      Chief Medical Officer
      Madison, Wisconsin

      Dr. Henry Anderson received his MD degree from the University of Wisconsin Medical School in 1972. He was certified in 1977 by the American Board of Preventive Medicine with a sub-specialty in occupational and environmental medicine and in 1983 became a fellow of the American College of Epidemiology. In 1980 he joined the Wisconsin Department of Health and Social Services as the Wisconsin State Environmental and Occupational Disease Epidemiologist. In 1991 he also assumed the duties of Chief Medical Officer. In July 2008 he was appointed Interim Wisconsin State Health Officer and served in that capacity until January 2009 at which time he returned to his Chief Medical Officer and State Epidemiologist duties. Since 1980 he has held adjunct Professorships at the University of Wisconsin - Madison, Department of Population Health Sciences and the UW Nelson Institute for Environmental Studies, Center for Human Studies. He has published over 230 scientific articles on a broad spectrum of environmental, occupational and public health topics. He is the past chair of the National Institute of Occupational Safety and Health Board of Scientific Councilors.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 13 KB (1 page)

    • Josie Beach
      Nuclear Chemical Operator
      Lead Hazardous Waste Trainer
      Lead Respiratory Trainer
      Ch2M Hill Hanford Group, Inc.
      Hanford
      Richland, Washington

      Ms. Josie Beach is a Nuclear Chemical Operator with 20 years of experience at the Hanford Nuclear Reservation. She started her Hanford career in 1987, at the Plutonium Finishing Plant (PFP) as an active participant in the plants final plutonium production campaign. In 1994, Ms. Beach became involved in the worker trainer worker program instructing and developing Health and Safety classes. Ms. Beach currently works for CH2M Hill in the Tank Farms waste operations group and is a member of the United Steel Workers Union Local 12-369.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 11 KB (1 page)

    • Bradley P. Clawson
      Senior Operator Nuclear Fuel Handling
      CMH2H-WG
      Idaho National Laboratory
      Idaho Falls, Idaho

      Mr. Clawson has been a Senior Operator in the Spent Nuclear fuels program at the Idaho National Laboratory since 1989. He has been involved in the shipping and receiving of the Nuclear Naval fuels, the recovery and storage of the Three Mile Island fuel, and received and stored Foreign Research Reactor fuels, as well as numerous other types of nuclear fuels. He also serves as the Nuclear Material Custodian. Mr. Clawson is involved in the troubleshooting and problem solving of daily problems and resolution of fuel handling as well as the design and fabrication of tools for the ongoing inventory of the fuels. He is a member as well as holding several offices in the United Steelworkers Union Local 8-652. Mr. Clawson was the former Secretary-Treasurer of the Atomic Energy Workers Council.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 15 KB (2 pages)

    • R. William Field, Ph.D., M.S.
      Professor
      College of Public Health
      University of Iowa
      Iowa City, Iowa

      Dr. Bill Field is a Professor at the University of Iowa's College of Public Health with joint appointments in the Department of Occupational and Environmental Health and Department of Epidemiology. He also directs NIOSH's funded Occupational Epidemiology Training Program as well as NIEHS' funded Environmental Lung Disease Research Cluster, which are both located at the University of Iowa. In addition, he is currently serving as a member of the EPA's Science Advisory Board, Radiation Advisory Committee. Dr. Field has received numerous honors for his research and service including the EPA's/ NEHA's Individual Achievement Award for Excellence in Radon Risk Reduction, the EPA's Children's Environmental Health Recognition Award, as well as other honorary society, professional association, and university awards. Previous service includes activities with the National Academy of Sciences, the World Health Organization, scientific journal editorial boards, and numerous national and international organizations. He received his Ph.D. in Preventive Medicine and Environmental Health from the College of Medicine at University of Iowa.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 13 KB (1 page)

    • Michael H. Gibson
      Retired Journeyman Electrician, Babcock & Wilcox of Ohio,
            E.G. & G., Mound Applied Technologies and
            Monsanto Research Corporation at the DOE
            Mound Facility
      Past President, Paper, Allied-Industrial, Chemical and
           Energy International Union, Local 5-4200
      Miamisburg, Ohio

      Mr. Gibson, now retired, served as a Journeyman Electrician at Babcock & Wilcox of Ohio, E.G. & G., Mound Applied Technologies and Monsanto Research Corporation at the DOE Mound Facility since 1981. He was responsible for installation, maintenance, demolition, and decontamination of radiological laboratories throughout the site.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 10 KB (1 page)

    • Mark Griffon
      President, Health Physicist
      Creative Pollution Solutions, Inc.
      Salem, New Hampshire

      Mark Griffon has served as the President of Creative Pollution Solutions in New Hampshire since 1992 where he performs consulting services in the radiation and hazardous waste fields. He also recently served as a Member of the Advisory Committee for U.S. Transuranium and Uranium Registries.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 11 KB (1 page)

    • Richard A. Lemen, Ph.D., M.S.P.H.
      Assistant Surgeon General
      United States Public Health Service (ret.)

      Dr. Lemen is a former Assistant Surgeon General of the United States Public Health Service. Since retiring from the United States Public Health Service in 1996, has been a private consultant engaged in issues involving the analysis of risks associated with occupational and environmental health. Dr. Lemen was also the Acting Director and the Deputy Director of the National Institute for Occupational Safety and Health (NIOSH) before his retirement. Since his retirement, he has taught graduate level classes on environmental and occupational health issues at the Rollins School of Public Health at the Emory University in Atlanta, Georgia. He has also testified in litigation on behalf of persons afflicted with asbestos-induced disease.

      He has been a practicing epidemiologist for over forty years. He holds a Bachelor of Arts degree from Central Methodist University in Zoology and Chemistry; Master's of Science Degree in Public Health from the University of Missouri in the field of epidemiology; PhD in epidemiology from the University of Cincinnati; and completed the Scholar Program from the Public Health Leadership Institute of the Schools of Public Health, University of California. Dr. Lemen has published widely in the field of occupational health.

      From 1967 through 1969, he served in the US. Army; from 1970 through 1996 he served as a Regular Corps Officer of the United States Public Health Service (USPHS) where he obtained the rank of Rear Admiral.

      During the course of his service with the US Army and the USPHS, he received multiple medals including the Distinguished Service Medal and the Meritorious Service Medal, the two highest honors bestowed by the USPHS on Commissioned Officers in the United States. He also received the Surgeon General's Exemplary Service Medal and several Commendation Medals from the USPHS and the US Army and the James P. Keogh Award for Outstanding Service in Occupational Safety and Health presented by NIOSH. Dr. Lemen also received the I.W. Abel Award for Courage in Public Service.

      Dr. Lemen is Co-Science Director of the Asbestos Disease Awareness Organization, an international organization for which he volunteers much of his time today. Dr. Lemen is also an elected Fellow of the Collegium Ramazzini, an internationally acclaimed Occupational Health Society, a member of the American Public Health Association, The Public Health Leadership Institute, The British Occupational Hygiene Society, the New York Academy of Sciences, and is an Associated Editor of the American Journal of Industrial Health. Dr. Lemen is also a Life member of the both the Retired Officers Association and the Reserve Officers Association.

    • James E. Lockey, M.D., M.S.
      University of Cincinnati College of Medicine
      Professor of Environmental Health and Internal Medicine
      Cincinnati, Ohio

      Dr. Lockey served as the Director of the Division of Occupational and Environmental Medicine, Department of Environmental Health at the University of Cincinnati from 1986 to 2005. Current appointments and activities of Dr. Lockey include Professor of Medicine (Pulmonary Medicine) and Professor Environmental Health (Occupational and Environmental Medicine) University of Cincinnati; Member of the Expert Panel of Fernald II Worker Settlement Fund; Member of United Auto Workers - GM and United Auto Workers - Delphi Occupational Health Advisory Boards.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 14 KB (2 pages)

    • Wanda I. Munn
      Senior Nuclear Engineer (Retired)
      Richland, Washington

      Ms. Munn is retired from the Advanced Reactor Development Division of Westinghouse Hanford Company in Richland, Washington. She has 20 years of experience in nuclear engineering disciplines, design, construction, acceptance testing, startup, nuclear safety, and operation of the Fast Flux Test Facility. Ms. Munn has served on the Richland City Council, is a member of her local Health Physics chapter, a life member of the American Nuclear Society, and a Fellow of the Society of Women Engineers.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 10 KB (1 page)

    • John W. Poston, Sr.
      Professor and Graduate Coordinator
      Department of Nuclear Engineering
      Texas A&M University
      College Station, TX

      Dr. Poston has served on the faculty of Texas A&M University in the Department of Nuclear Engineering for 21 years, including 10 years as Head of the Department. His service on various advisory committees and activities also include the Radiation Advisory Committee, Science Advisory Board, Environmental Protection Agency; the National Academies Committee on Transportation of Nuclear Waste to Yucca Mountain; and the National Academies Committee on Controlling International Radiological Terrorism. He is a Fellow of the Health Physics Society, the American Nuclear Society, and the American Association for the Advancement of Science, and is an Honorary Member of the National Council on Radiation Protection and Measurements. Dr. Poston is also an Associate Editor of the Health Physics Journal.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 15 KB (2 pages)

    • David B. Richardson, Ph.D.
      Associate Professor
      Department of Epidemiology,
      School of Public Health,
      University of North Carolina
      Chapel Hill, North Carolina

      David B. Richardson is Associate Professor of Epidemiology in the School of Public Health at the University of North Carolina at Chapel Hill. His research investigates occupational and environmental causes of disease, with a particular focus on ionizing radiation. He has served in various capacities at the University of North Carolina since 1996 when he began as a post-doctoral researcher. In addition to his time at UNC, he has led a number of studies of workers at US Department of Energy facilities focused on occupational health and radiation exposure issues. Previously, he has spent time working at the World Health Organization's International Agency for Research on Cancer in Lyon, France and at the Radiation Effects Research Foundation in Hiroshima, Japan. He received his B.A. in political science from Duke University and a Ph.D. in epidemiology from the University of North Carolina at Chapel Hill.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 13 KB (1 page)

    • Genevieve S. Roessler, Ph.D.
      Radiation Consultant
      Professor Emeritus
      University of Florida
      Elysian, Minnesota

      Dr. Roessler was on the faculty, Department of Nuclear Engineering, University of Florida for 22 years as Head of Health Physics and Medical Physics. Various advisory committees include the Radiation Advisory Committee, Science Advisory Board, Environmental Protection Agency, 1997-2004; Technical Steering Panel, Hanford Environmental Dose Reconstruction Project, 1988-1996; and Bi-national Advisory Group, Chernobyl Health Effects Study, National Cancer Institute, 2001-present. Dr. Roessler is also the Editor-in-Chief of the Health Physics Society's Newsletter and Web Site.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 12 KB (1 page)

    • Phillip Schofield
      Bosque Farm, New Mexico

      Mr. Schofield worked for Los Alamos National Laboratory for twenty one years. He has extensive experience in handling and processing of plutonium and americium. Some of the areas of actinide chemistry and processing include: 1) making fuel and fuel pins for the FFTF program using plutonium, uranium, and thorium, 2) hydrogen fluoride reduction of Pu O2, direct oxide reduction, americium extraction, and recovery of Pu metal. Mr. Schofield spent the last five years as an Operations Center Specialist , running and monitoring all systems at the (TA-55) plutonium facility. He has been on medical disability since 1996. He has since worked as a volunteer with the Los Alamos Project on Worker Safety.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 13 KB (1 page)

    • Paul L. Ziemer, Ph.D.
      Professor Emeritus
      School of Health Sciences
      Purdue University
      West Lafayette, Indiana

      Dr. Paul Ziemer is Professor Emeritus and former Head of the School of Health Sciences at Purdue University in West Lafayette, Indiana. From 1990 to 1993, Dr. Ziemer served as the Assistant Secretary of Energy for Environment, Safety, and Health during the Bush Administration. From 1995-2001, Dr. Ziemer was a consultant for the Advanced Technologies and Laboratories, Inc., and served as Chairman of the Board from 1999-2001. He earlier served as a health physicist at the Oak Ridge National Laboratory, a Radiological Physics Fellow at Vanderbilt University, and a physicist at the U.S. Naval Research Laboratory in Washington, D.C. He is a Certified Health Physicist and has been President of the Health Physics Society and of the American Academy of Health Physics. He has also served a term as a member of the American Board of Health Physics. Dr. Ziemer currently serves on the Board of Directors of the Radiation Effects Research Foundation (Hiroshima, Japan) and as a member of the Nuclear and Radiation Studies Board of the National Academy of Sciences.

      Conflict of Interest Disclosure Statement
      this document in PDF PDF 15 KB (2 pages)

  • Previous Board Members

    • Henry Anderson (January 2002 through January 2006)

    • Antonio Andrade (January 2002 through February 2005)

    • Roy DeHart (January 2002 through August 2006)

    • Larry Elliott (January 2002 through February 2005)

    • Richard Espinosa (January 2002 through January 2006)

    • Sally Gadola (January 2002 through November 2002)

    • Lew Wade (February 2005 through April 2008)

    • Charles Leon Owens (October 2002 through September 2006)

    • Robert W. Presley (2001 through September 2011)

Top of Page

Contacting the Advisory Board

The Advisory Board welcomes written comments from claimants, advocates, energy employees, Congressional offices, and the general public. Comments can be faxed to the attention of the Advisory Board at 513-533-6826 or submitted electronically by e-mail to dcas@cdc.gov or ocas@cdc.gov.

Top of Page

Advisory Board Subcommittee and Work Group Information

Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. Where documents have been finalized, they may be reviewed, and protected information is removed so that the documents may be provided to the SEC petitioners. These finalized, reviewed and redacted documents are also available to other interested parties through an appropriate Freedom of Information Act (FOIA) request. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.


Subcommittees

Structure

A subcommittee of the Advisory Board is subject to Federal Advisory Committee Act (FACA) requirements, including open meetings and appropriate announcements in the Federal Register. The subcommittee may meet in closed session, in accordance with the same FACA procedures that apply to the Board itself. The subcommittee will take direction from, and will report back to, the full Board for consideration and appropriate action on all matters.

Frequency of Meetings

The subcommittee will meet approximately 12 times per year with additional meetings on an as-needed basis. Meetings may be called by the Designated Federal Official with the concurrence of the Board Chair or the Subcommittee Chair.

  • Subcommittee on Dose Reconstruction Reviews

    The Dose Reconstruction Subcommittee is responsible for the review and recommendation for Board action, of the Board's Technical Support Contractor's audit procedures (including revisions) related to dose reconstructions conducted by the NIOSH DCAS. This Subcommittee will:

    • Clarify Board intent with regard to the technical scope of dose reconstruction tasks assigned to the Board's Technical Support Contractor;

    • Select cases for individual dose reconstruction review consistent with Board procedures, taking into consideration conflict of interest matters;

    • Assign cases for individual reviews to Board "Review Panels" (taking into account Board members' conflict of interest standing), and ensuring a balance of scientific, medical and worker perspectives;

    • Compile the Review Panels' recommendations/findings (including dose reconstruction review summary reports) for submission to the Board, with the assistance of the Board's contractor;

    • Develop summary reports for the Board to advise the Secretary from time to time on nature and impact of its findings; and

    • Advise the Secretary on the scientific validity and appropriateness of the dose reconstructions carried out by NIOSH.

    Members:

    Mark Griffon-Chair
    Michael H. Gibson
    Wanda I. Munn
    John W. Poston, Sr.
    David B. Richardson, Ph.D.
    Bradley P. Clawson-Alternate

  • Subcommittee on Procedures Review

    The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by NIOSH DCAS and its dose reconstruction contractor. These reviews will involve the technical support contractor to the Board, whose technical reviews of procedures comprise a major component of the overall review process, DCAS and its dose reconstruction contractor, the Subcommittee, and the full committee of the Board, to which the Subcommittee will report. The Subcommittee may develop reports for the Board to advise the Secretary on the scientific validity and appropriateness of the procedures used by DCAS and its contractor for dose reconstruction and related activities.

    The Subcommittee will conduct the following tasks:

    • Select individual procedures to be reviewed, consistent with Board policies and direction

    • Provide guidance regarding procedure reviews to the Board's technical support contractor, as necessary

    • Prepare documents or periodic oral reports to the Board concerning the status of procedures reviews

    • Review correspondence received by the Board related to procedures review, and prepare responses for the Board Chair's signature in accordance with Board policies

    • Review the results of procedures reviews, including the findings of the Board's technical support contractor and issues identified by Board members; ensure that these findings and issues are considered by NIOSH; and participate in, and track the resolution of these findings and issues by NIOSH, the Board's technical contractor, the Subcommittee, and, as necessary and appropriate, by the full committee of the Board.

    Members:

    Wanda I. Munn-Chair
    Michael H. Gibson
    Richard A. Lemen, Ph.D., M.S.P.H.
    Paul L. Ziemer, Ph.D.

Work Groups

  • Area IV of the Santa Susana Field Laboratory Work Group

    This Work Group is responsible reviewing the SEC petition from the Santa Susana Field Laboratory petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues that may be raised by the Board's contractor (SC&A) concerning the NIOSH Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Michael H. Gibson-Chair
    Josie Beach
    Wanda I. Munn
    Phillip Schofield

  • Blockson Chemical Company Work Group

    This Work Group is responsible for reviewing the SEC petition from Blockson Chemical Company petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor S. Cohen & Associates (SC&A), and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Wanda I. Munn-Chair
    Michael H. Gibson
    James Malcolm Melius, M.D., Dr. P.H.
    Genevieve S. Roessler, Ph.D.
    Bradley P. Clawson--Alternate

  • Brookhaven National Laboratory Work Group

    This Work Group is responsible for reviewing the SEC petition from Brookhaven National Laboratory petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor SC&A, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Josie Beach-Chair
    Henry A. Anderson, M.D.
    Brad Clawson
    Wanda I. Munn
    Genevieve S. Roessler, Ph.D.

  • Chapman Valve Work Group

    (Task completed)

    This Work Group is responsible for reviewing the SEC petition from the Chapman Valve petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor (SC&A), and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    John W. Poston, Sr.-Chair
    Bradley P. Clawson
    Michael H. Gibson
    Mark Griffon
    Genevieve S. Roessler, Ph.D.

  • Conflict of Interest Policy for the Board Work Group

    (Inactive)

    This Work Group was intended to assist the Board in developing a Conflict of Interest Policy within the parameters of the NIOSH/HHS Conflict of Interest Policy. However, HHS has determined that its Department's ethics policies are adequate to cover the Board. Hence, the Work Group was not activated.

    James E. Lockey, M.D., M.S.-Chair
    James Malcolm Melius, M.D., Dr. P.H.
    Paul L. Ziemer, Ph.D.

  • Department of Energy Security Work Group

    This Work Group is charged to prepare, for consideration by the Board, a Draft Security Plan that outlines the procedures the Board and its contractor will use to comply with the NIOSH/HHS and DOE Security Plan.

    Bradley P. Clawson-Chair
    Josie Beach
    Michael H. Gibson--Alternate

  • Fernald Work Group

    This Work Group is responsible for reviewing the Fernald Site Profile, the SEC petition from Fernald petitioners, the NIOSH Evaluation Report of the petition, the SC&A Review of the Fernald Site Profile, considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Bradley P. Clawson-Chair
    Mark Griffon
    Phillip Schofield
    Paul L. Ziemer, Ph.D.

  • Hanford Work Group

    This Work Group is responsible for reviewing the Hanford Site Profile (as revised), the SEC petition(s) from Hanford petitioners, the NIOSH Evaluation Report of the petition, and the SC&A Review of the Hanford Site Profile. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    James Malcolm Melius, M.D., Dr. P.H.-Chair
    Bradley P. Clawson
    John W. Poston, Sr.
    Phillip Schofield
    Paul L. Ziemer, Ph.D.

  • Idaho National Laboratory Work Group

    This Work Group is responsible for a review of the Idaho National Laboratory Site Profile and a review of the Site Profile by the Board's contractor (SC&A). The Work Group shall consider issues identified by SC&A concerning the Site Profile and shall assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Josie Beach
    James Malcolm Melius, M.D., Dr. P.H.
    Genevieve S. Roessler, Ph.D.
    David B. Richardson, Ph.D.--Alternate

  • K-25, Paducah, and Portsmouth (Gaseous Diffusion Plants/GDP) Work Group

    This Work Group is responsible for reviewing the Site Profiles for K-25, Paducah, and Portsmouth, and the SC&A reviews of these Site Profiles. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profiles, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Henry A. Anderson, M.D.
    Josie Beach

  • Lawrence Berkeley National Laboratory (LBNL) Work Group

    This Work Group is responsible for reviewing the LBNL Site Profile, the SEC petition from LBNL petitioners, the NIOSH Evaluation Report of the petition, the SC&A Review of the LBNL Site Profile, considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Paul L. Ziemer, Ph.D.-Chair
    Richard A. Lemen, Ph.D., M.S.P.H.
    David B. Richardson, Ph.D.

  • Linde Ceramics Plant Work Group

    This Work Group is responsible for reviewing the SEC petition from the Linde Ceramics Plant petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor (SC&A), and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Genevieve S. Roessler, Ph.D.-Chair
    Josie Beach
    Michael H. Gibson
    James E. Lockey, M.D., M.S.

  • Los Alamos National Laboratory (LANL) Work Group

    This Work Group is responsible for reviewing the Los Alamos Site Profile (as revised), the SEC petition(s) from Los Alamos petitioners, the NIOSH Evaluation Report of the petition, the SC&A Review of the Los Alamos Site Profile. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Mark Griffon-Chair
    Josie Beach
    James E. Lockey, M.D., M.S.
    Wanda I. Munn

  • Mound Plant Work Group

    This Work Group is responsible for reviewing the SEC petition from the Mound petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor (SC&A), and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group must independently evaluate the integrity and completeness of the data upon which dose reconstructions are based. The Work Group will consider the assumptions and judgments of historical facts provided in the Evaluation Report and develop appropriate recommendations for the Board's consideration. The Work Group will also consider any reviews provided by SC&A regarding the petition, and will use a deliberative process to narrow the scope of the SEC important issues and questions. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Josie Beach-Chair
    Bradley P. Clawson
    Phillip Schofield
    Paul L. Ziemer, Ph.D.--Alternate

  • Nevada Test Site Work Group

    The Nevada Test Site (NTS) Site Profile Work Group was formed in the Spring of 2006. The Work Group was formed to review the NTS Site Profile document for accuracy and authenticity. In January, 2008, the Board tasked the Work Group with reviewing the petition from NTS for adding a class to the SEC. The Work Group is responsible for reviewing the NIOSH Evaluation Report (ER), the SC&A review of the ER, reviewing the SC&A Site Profile Review, and for tracking the resolution process for SC&A findings and NIOSH responses. The Work Group may recommend to the Board, changes in the site profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Bradley P. Clawson
    Wanda I. Munn
    Genevieve S. Roessler, Ph.D.
    Phillip Schofield

  • Oak Ridge Gaseous Diffusion Plant (K-25), Paducah Gaseous Diffusion Plant, and Portsmouth Gaseous Diffusion Plant Work Group

    This Work Group is responsible for reviewing the Site Profiles for K-25, Paducah, and Portsmouth, and the SC&A reviews of these Site Profiles. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profiles, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Henry A. Anderson, M.D.
    Josie Beach

  • Oak Ridge Hospital Work Group

    (Task completed on October 21, 2009)

    This Work Group is responsible for reviewing the SEC petition from the Oak Ridge Hospital petitioners, reviewing the DCAS Evaluation Report of the petition, and considering and resolving issues generated through these reviews. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC. The Work Group should emphasize the following in its review: (1) examine the extent of the records sought and obtained by DCAS and seek to obtain any additional records that might be indicated and available on a timely basis; (2) consider further the radiation exposure potential of persons employed at the facility; and, (3) consider the possible employment practices at the Hospital as they might relate to any class definition to be established.

    James E. Lockey, M.D., M.S.-Chair
    John W. Poston, Sr.
    Genevieve S. Roessler, Ph.D.
    Phillip Schofield

  • Paducah, K-25, and Portsmouth (Gaseous Diffusion Plants/GDP) Work Group

    This Work Group is responsible for reviewing the Site Profiles for Paducah, K-25, and Portsmouth, and the SC&A reviews of these Site Profiles. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profiles, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Henry A. Anderson, M.D.
    Josie Beach

  • Pantex Plant Work Group

    This Work Group is responsible for reviewing the Pantex Plant Site Profile, the SEC petition from Pantex Plant petitioners, the NIOSH Evaluation Report of the petition, the SC&A Review of the Pantex Plant Site Profile, considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Bradley P. Clawson-Chair
    Phillip Schofield
    Josie Beach--Alternate

  • Pinellas Plant Work Group

    This Work Group is responsible to review the Pinellas Plant Site Profile (as revised), to review the SC&A Review of the Pinellas Site Profile, to consider issues raised by the Board's contractor (SC&A) concerning the Site Profile, and to assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Bradley P. Clawson
    John W. Poston, Sr.
    Michael H. Gibson--Alternate

  • Piqua Organic Moderated Reactor Work Group

    (Task Completed)

    This Work Group is responsible for reviewing the SEC petition from Piqua Moderated Reactor petitioners, reviewing the NIOSH Evaluation Report of the petition, considering issues raised by the Board's contractor SC&A, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    John W. Poston, Sr.-Chair
    R. William Field, Ph.D., M.S.
    Phillip Schofield

  • Portsmouth, Paducah, and K-25 (Gaseous Diffusion Plants/GDP) Work Group

    This Work Group is responsible for reviewing the Site Profiles for Portsmouth, Paducah, and K-25, and the SC&A reviews of these Site Profiles. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profiles, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.

    Phillip Schofield-Chair
    Henry A. Anderson, M.D.
    Josie Beach

  • Review of SEC Petitions that Did Not Qualify for Evaluation Work Group

    (Task completed on May 2, 2007)

    The charge of this Work Group was to review disqualified special exposure cohort petitions and the process followed by NIOSH and the rationale for petition disqualification. The conclusions of the Work Group were that the final rule as reflected in the legislation was followed, and NIOSH's review of the petition was claimant friendly. The Work Group provided a number of recommendations with regard to making the process of submitting a Special Exposure Cohort more user friendly.

    James E. Lockey, M.D., M.S.-Chair
    Bradley P. Clawson
    James Malcolm Melius, M.D., Dr. P.H.
    Wanda I. Munn
    Genevieve S. Roessler, Ph.D.

  • Rocky Flats Plant Work Group

    This Work Group is responsible for reviewing the Rocky Flats Plant Site Profile (as revised), reviewing the SEC petition(s) from Rocky Flats petitioners, reviewing the NIOSH Evaluation Report of the petition, reviewing the SC&A Review of the Rocky Flats Plant Site Profile. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Mark Griffon-Chair
    Michael H. Gibson
    Wanda I. Munn

  • Sandia National Laboratories (New Mexico) Work Group

    This Work Group is responsible for a review of the Sandia National Laboratories (SNL - New Mexico) Site Profile and of the draft review of this Site Profile by the Board's contractor (SC&A). The Work Group shall consider issues identified by SC&A concerning the Site Profile and shall assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate. The Work Group may also be assigned to review Special Exposure Cohort petitions for SNL that may be received and evaluated by NIOSH, together with the NIOSH Evaluation Reports and SC&A review reports for such petitions.

    Richard A. Lemen, Ph.D., M.S.P.H.--Chair
    Henry A. Anderson, M.D.
    Josie Beach
    Genevieve S. Roessler, Ph.D.

  • Savannah River Site Work Group

    This Work Group is responsible for a review of the Savannah River Site Profile (as revised) and a review of the Site Profile by the Board's contractor (SC&A). The Work Group shall consider issues identified by SC&A concerning the Site Profile and shall assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate. The Work Group is also responsible for a review of SEC petitions from Savannah River Site petitioners, the resultant SEC Petition Evaluations from NIOSH, and any SC&A reviews of the SEC Petitions and NIOSH Petition Evaluations. The Work Group shall assist NIOSH and SC&A in the resolution of issues concerning the petitions and should strive to develop a recommendation to the Board on whether a class should be added to the SEC.

    Mark Griffon-Chair
    Bradley P. Clawson
    Michael H. Gibson
    James E. Lockey, M.D., M.S.
    Phillip Schofield

  • Scientific Issues Work Group

    This Work Group is responsible for reviewing the status of a number of risk model issues that have been identified as important for the EEOICPA program. These include the possible incorporation of nuclear worker epidemiological studies into IREP risk models; Dose and Dose-rate Effectiveness Factor adjustment; adjustment for the interaction with smoking for certain cancers; grouping of rare and miscellaneous cancers; age-at-exposure analysis; and interaction between radiation and other workplace exposures. The work group will review the status of NIOSH's current work on these issues and report back to the full Board with recommendations. The work group will also report on any new risk model issues that they believe that the Board should consider for recommendation to NIOSH.

    David B. Richardson, Ph.D.-Chair
    R. William Field, Ph.D., M.S.
    Richard A. Lemen, Ph.D., M.S.P.H.
    James E. Lockey, M.D., M.S.
    Wanda I. Munn
    John W. Poston, Sr.
    Genevieve S. Roessler, Ph.D.
    Paul L. Ziemer, Ph.D.

  • Special Exposure Cohort (SEC) Issues (including the 250 day issue) Work Group

    This Work Group has two primary responsibilities: 1) To serve as a review body for SEC petitions that result from NIOSH determining that it is unable to reconstruct dose for one or more individuals at a given site (83.14 SEC petition process); 2) To consider potential conditions under which significant personnel exposures might occur (in addition to criticality accidents) in short periods of time (less than 250 days) resulting in health effects. In the case of specific 83.14 petitions, the Work Group may make a recommendation to the Board either in support of the NIOSH recommendation to add a class to the SEC, or in opposition to such. In the case of the 250 day issue, the Work Group should strive to develop a position paper that can be adopted by the Board. In addition, this Work Group is also responsible for reviewing the Dow-Madison SEC petition and related documents, and developing a recommendation for the Board.

    James Malcolm Melius, M.D., Dr. P.H.-Chair
    Josie Beach
    Genevieve S. Roessler, Ph.D.
    Paul L. Ziemer, Ph.D.

  • TBD 6000 Work Group

    This Work Group is responsible for the review of the specified TBDs, as well as the Appendices that apply to specific work sites. They will also review any reports developed by the Board's contractor (SC&A) pertaining to these TBDs and the Appendices, and will assist NIOSH and SC&A in resolving issues that arise through the review process. The initial focus of the Work Group will be on Appendix BB of TBD 6000, dealing with General Steel Industries. The Work Group will make recommendations to the Board in cases where Appendices involve sites with SEC petitions. Sites currently being considered under this TBD by the Work Group include General Steel Industries and Bliss & Laughlin Steel.

    Paul L. Ziemer, Ph.D.-Chair
    Josie Beach
    John W. Poston, Sr.
    Wanda I. Munn--Alternate

  • TBD 6001 Work Group
    (This Work Group has changed its name to the Uranium Refining Atomic Weapons Employers (AWEs) Work Group)

  • TBD 6000/6001, Appendix BB Work Group

    This Work Group no longer exists. In March 2010, this Work Group was divided into two separate Work Groups--Advisory Board Work Group on TBD 6000 and Advisory Board Work Group on TBD 6001.

    This Work Group is responsible for the review of the specified TBDs as well as the Appendices that apply to specific work sites. They will also review any reports developed by the Board's contractor (SC&A) pertaining to these TBDs and the Appendices, and will assist NIOSH and SC&A in resolving issues that arise through the review process. The initial focus of the Work Group will be on Appendix BB of TBD 6000, dealing with General Steel Industries. The Work Group will make recommendations to the Board in cases where Appendices involve sites with SEC petitions.

    Paul L. Ziemer, Ph.D.-Chair
    Josie Beach
    Mark Griffon
    John W. Poston, Sr.
    Wanda I. Munn--Alternate

  • Uranium Refining Atomic Weapons Employers (AWEs) Work Group
    (formerly TBD 6001 Work Group)

    This Work Group is responsible for the review of TBDs and SEC petitions for uranium refining AWEs as assigned to it by the Board. It will also review any reports developed by the Board's contractor (SC&A) pertaining to these TBDs and SEC petitions, and will assist NIOSH and SC&A in resolving issues that arise through the review process. The Work Group will make recommendations to the Board regarding such SEC petitions. Sites currently being considered by the Work Group include Baker-Perkins Co., Du Pont Deepwater Works, Electro Metallurgical, Hooker Electrochemical, and United Nuclear Corp.

    Henry A. Anderson, M.D.-Chair
    R. William Field, Ph.D., M.S.
    Mark Griffon

  • Use of Surrogate Data Work Group

    This Work Group will consider the conditions under which "surrogate" data can be used as a valid substitute for actual data for a given site. The Work Group will seek to establish the type and importance of various parameters (e.g., type of nuclide, amounts of material, chemical and physical forms, processes, working conditions, and other such parameters) that impact on worker dose, and will consider the extent to which such parameters at one site may apply to other sites. The Work Group may also consider the extent to which theoretical considerations can be properly used to bound dosed in the absence of actual workplace measurements. The Work Group should strive to develop a policy recommendation that can be adopted by the Board regarding the use of surrogate data. This Work Group was asked to consider the application of surrogate data criteria to the Texas City Chemicals, Inc., site in relation to the SEC petition for that facility.

    James Malcolm Melius, M.D., Dr. P.H.-Chair
    Josie Beach
    Mark Griffon
    James E. Lockey, M.D., M.S.
    Wanda I. Munn

  • Weldon Spring Work Group

    This Work Group is responsible for reviewing the Weldon Spring Site Profile, SEC petitions from Weldon Spring petitioners, the NIOSH Evaluation Report of the petition, and the SC&A Review of the Weldon Spring Site Profile. It is also responsible for considering issues raised by the Board's contractor (SC&A) concerning the Site Profile and SEC petitions, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendations to the Board on whether a class should be added to the SEC.

    Michael H. Gibson-Chair
    Richard A. Lemen, Ph.D., M.S.P.H.

  • Worker Outreach Work Group

    This Work Group will monitor the NIOSH Worker Outreach program and evaluate its effectiveness. To do so, Work Group members will attend outreach meetings as appropriate, review minutes and related documents that are generated at such meetings, and talk to workers and other participants when necessary. The Work Group should consider developing a formal assessment instrument (such as a follow-up questionnaire). The Work Group should report its findings to the Board from time to time, and make recommendations to the Board as it deems appropriate.

    Michael H. Gibson-Chair
    Josie Beach
    Wanda I. Munn
    Phillip Schofield

Top of Page

Advisory Board Procedures


Top of Page

2012 Advisory Board Meetings (includes agendas, minutes, and transcripts)


The Advisory Board must adhere to the Federal Advisory Committee Act (FACA). FACA ensures that advice rendered by the Advisory Board be both objective and accessible to the public. In addition, FACA requires that notices for committee meetings are published with adequate advance notice in the Federal Register. The Advisory Board has established both subcommittees and work groups. While FACA does not require a notice to be published in the Federal Register for work group meetings, we will make every attempt to provide advanced notice of work group meetings held by the Advisory Board.

Locations, times, telephone conference access information, agendas, minutes, and transcripts for the Advisory Board meetings are included in this section. To locate a meeting, click on one of the months below. A list of meetings that occurred during that month will be displayed. The most recent meetings are located at the top of the list.

JAN      FEB      MAR      APR

NOTE: Transcripts posted to the Web site after December 12, 2007, will be posted in accordance with the following policy:

Policy on Redaction of Board Meeting Transcripts
(Public Comment)

  1. If a person making a comment gives his or her name, no attempt will be made to redact that name.

  2. NIOSH will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include:

    1. A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted;

    2. A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comment;

    3. A statement such as outlined in (a) above will also appears with the agenda for a Board Meeting when it is posted on the NIOSH Web site;

    4. A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings.

  3. If an individual in making a statement reveals personal information (e.g., medical information) about themselves that information will not usually be redacted. The NIOSH FOIA coordinator will, however, review such revelations in accordance with the Freedom of Information Act and the Federal Advisory Committee Act and if deemed appropriate, will redact such information.

  4. All disclosures of information concerning third parties will be redacted.

  5. If it comes to the attention of the Designated Federal Official (DFO) that an individual wishes to share information with the Board but objects to doing so in a public forum, the DFO will work with that individual, in accordance with the Federal Advisory Committee Act, to find a way that the Board can hear such comments.

NIOSH Procedures for Providing Public Access to Records or Documents of the Advisory Board on Radiation and Worker Health (the Board)
(November 11, 2009)
this document in PDF PDF 38 KB (6 pages)

April Public Meetings

Meeting Dates and Short Descriptions

Advisory Board meeting dates and short descriptions are listed below. Click on the meeting date for additional information.

April 11 Meeting of the Advisory Board's Subcommittee on Procedures Review
April 10 Meeting of the Advisory Board's Work Group on Mound Plant

Detailed Meeting Information

Additional information such as Advisory Board meeting locations, times, telephone conference access information, agendas, minutes, and transcripts is provided below.

  • April 11
    Meeting of the Advisory Board's Subcommittee on Procedures Review

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a later date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • April 10
    Meeting of the Advisory Board's Work Group on Mound Plant

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a later date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

Select a Different Month

Top of Page

March Advisory Board Meetings

Meeting Dates and Short Descriptions

Advisory Board meeting dates and short descriptions are listed below. Click on the meeting date for additional information.

Meeting Date Meeting Description
March 30 Meeting of the Advisory Board's Subcommittee on Dose Reconstruction Reviews
March 16--POSTPONED Meeting of the Advisory Board's Work Group on Mound Plant
March 15 Meeting of the Advisory Board's Work Group on TBD 6000

Detailed Meeting Information

Additional information such as Advisory Board meeting locations, times, telephone conference access information, agendas, minutes, and transcripts is provided below.

  • March 30
    Meeting of the Advisory Board's Subcommittee on Dose Reconstruction Reviews

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a later date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • March 16--POSTPONED
    Note: This meeting will be rescheduled at a later date.

    Meeting of the Advisory Board's Work Group on Mound Plant

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a later date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • March 15
    Meeting of the Advisory Board's Work Group on TBD 6000

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a later date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

Select a Different Month

Top of Page

February Advisory Board Meetings

Meeting Dates and Short Descriptions

Advisory Board meeting dates and short descriptions are listed below. Click on the meeting date for additional information.

Meeting Date Meeting Description
February 28-29 Meeting of the Advisory Board on Radiation and Worker Health
February 21 Meeting of the Advisory Board's Work Group on Brookhaven National Laboratory
February 15 Teleconference Meeting of the Advisory Board's Work Group on Linde Ceramics Plant
February 14 Teleconference Meeting of the Advisory Board's Work Group on Uranium Refining Atomic Weapons Employers (AWEs)

Teleconference Meeting of the Advisory Board's Work Group on Weldon Spring Plant
February 9 Meeting of the Advisory Board's Work Group on Fernald
February 3 Meeting of the Advisory Board's Work Group on Lawrence Berkeley National Laboratory

Detailed Meeting Information

Additional information such as Advisory Board meeting locations, times, telephone conference access information, agendas, minutes, and transcripts is provided below.

  • February 28-29
    Meeting of the Advisory Board on Radiation and Worker Health

    Waterfront Hotel
    10 Washington St.
    Oakland, CA 94607
    Phone: (510) 836-3800
    Fax: (510) 832-6228

    An agenda will be provided at a separate date.

  • February 21
    Teleconference Meeting of the Advisory Board's Work Group on Brookhaven National Laboratory

    11:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a separate date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • February 15
    Teleconference Meeting of the Advisory Board's Work Group on Linde Ceramics Plant

    10:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 26 KB (1 page)

    Discussion Papers:

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • February 14
    Teleconference Meeting of the Advisory Board's Work Group on Uranium Refining Atomic Weapons Employers (AWEs)

    2:00 p.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 105 KB (1 page)

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • February 14
    Teleconference Meeting of the Advisory Board's Work Group on Weldon Spring Plant

    10:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    An agenda will be provided at a separate date.

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • February 9
    Meeting of the Advisory Board's Work Group on Fernald

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 20 KB (2 pages)

    Discussion Papers:

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • February 3
    Meeting of the Advisory Board's Work Group on Lawrence Berkeley National Laboratory

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 22 KB (1 page)

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

Select a Different Month

Top of Page

January Advisory Board Meetings

Meeting Dates and Short Descriptions

Advisory Board meeting dates and short descriptions are listed below. Click on the meeting date for additional information.

Meeting Date Meeting Description
January 30 Meeting of the Advisory Board's Work Group on Linde Ceramics Plant
January 9 Meeting of the Advisory Board's Work Group on Subcommittee on Procedures Review

Detailed Meeting Information

Additional information such as Advisory Board meeting locations, times, telephone conference access information, agendas, minutes, and transcripts is provided below.

  • January 30
    Meeting of the Advisory Board's Work Group on Linde Ceramics Plant

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 26 KB (1 page)

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

  • January 9
    Meeting of the Advisory Board's Subcommittee on Procedures Review

    Cincinnati Airport Marriott
    2395 Progress Dr.
    Hebron, KY 41048
    (859) 586-0166

    9:00 a.m. (Eastern time)

    This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

    Agenda
    this document in PDF PDF 14 KB (1 page)

    Transcript
    this document in PDF PDF 1.4 MB (273 pages)

    Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

Select a Different Month

Top of Page

Technical Support for the Board's Review of NIOSH Dose Reconstruction Program

CDC has a requirement to provide technical assistance to the Advisory Board on Radiation and Worker Health. The work involves conducting individual dose reconstruction reviews, Site Profile and worker profile reviews, and review of Special Exposure Cohort (SEC) petitions.

Top of Page

Reports from the Technical Support Contractor

Top of Page

Recommendations on SEC Petitions

Top of Page

Board Correspondence and Miscellaneous Items

Top of Page

Page last updated: February 9, 2012
Page last reviewed: January 4, 2011
Content Source: National Institute for Occupational Safety and Health (NIOSH) Division of Compensation Analysis and Support